Wed.Oct 13, 2021

article thumbnail

NIH study finds mixing COVID-19 boosters increases immune response

Bio Pharma Dive

Results suggested Pfizer's and Moderna's vaccines may serve as a more potent booster for those who initially received Johnson & Johnson's shot, although data are limited and preliminary.

article thumbnail

Pharmapack Europe 2021 Award Winners Announced

Pharma Mirror

Paris, Pharmapack Europe (#PharmapackEU) announce the winners of the 2021 Pharmapack Awards and, due to the exceptional quality of this year’s entries, seven winners have been chosen across both the ‘Exhibitor Innovation’ and ‘Health Product’ awards. The Exhibitor Innovation awards recognise four winners plus one highly commended product. EVEON was given the ‘routes of administration’ innovation award for their Intuity® Spray.

Packaging 246
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Intellia looks to eye diseases in latest deal

Bio Pharma Dive

The gene editing company will take a 10% stake in SparingVision, a young biotech that will use Intellia's CRISPR technology to develop treatments for up to three ocular targets.

article thumbnail

Will pharma ever get digital?

World of DTC Marketing

SUMMARY : Digital marketing is too damn important to leave to your agency. Pharma needs to develop digital marketing expertise in-house and have marketing people integrated within each brand team. There it was again. I was hired to do an analytic report for a client’s website, and the results were poor. Although the raw number of visitors was in the thousands, the bounce rate was 89%, time on site was under a minute and pages viewed was 1.8.

Branding 218
article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

FDA staff take neutral stance on Moderna, J&J boosters ahead of two-day meeting

Bio Pharma Dive

In briefing documents, agency scientists emphasized both vaccines still offer strong protection against severe COVID-19, but acknowledged potential for some added benefit with another dose.

Scientist 204
article thumbnail

Sales manager

pharmaphorum

This is an exciting opportunity to join pharmaphorum, contributing to our revenue targets, meeting new clients and supporting the development and launch of new offerings within the company’s leading international life science industry publications. This role will give you an excellent opportunity to further develop and sharpen your commercial skills at all angles in a company that is currently expanding.

Sales 98

More Trending

article thumbnail

Cadbury Recreates its Famous Dairy Milk Chocolate Bar and Makes It Vegan

XTalks

Just like KitKat and Hershey’s , Cadbury has introduced new plant-based chocolate called Cadbury Plant Bar. For a company known for its creamy Dairy Milk chocolate, it is exciting to see that they are also introducing plant-based products. Rather than using cow’s milk to create the creaminess of the product, this vegan chocolate will use almond paste as a vegan substitute.

article thumbnail

Are You a Woman in Healthcare? 6 Tips for Advancing Your Leadership Skills & Opportunities

Pharma Marketing Network

At the 7 th Advancing Women’s Leadership Skills & Opportunities in Pharma & Healthcare conference, top executives from across the pharmaceutical industry gathered to share their personal stories of success and perseverance to educate and inspire the next generation of female leaders. Despite a growing emphasis on diversity & inclusion and a more accepted understanding of the business impact that can be achieved through greater gender balance in organizational leadership, women still

98
article thumbnail

Merck’s Keytruda Notches Win in First-Line Cervical Cancer

BioSpace

Today’s approval was based on the Phase III KEYNOTE-826 trial that evaluated Keytruda and chemotherapy with or without bevacizumab compared to the same chemotherapy treatment.

Trials 98
article thumbnail

Sanofi’s BTK inhibitor tolebrutinib shows ‘promising’ long-term MS data

Pharma Times

Tolebrutinib reduced multiple sclerosis (MS) disease activity as measured by MRI

133
133
article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

It’s time to rethink the physician-pharma relationship

pharmaphorum

The traditional sales channel for the pharmaceutical industry has centered on face-to-face interaction with its core target audience – prescribing physicians. What happens when suddenly that form of interaction is taken away? Michael Brandreth, group vice president at WebMD Global, tells us how the events of the last 18 months make it more important than ever for pharma to reimagine how to reach its base in a new, more holistic way.

Sales 96
article thumbnail

Data supports early COVID-19 vaccination for essential workers

Scienmag

In areas where COVID-19 vaccines are limited, vaccinating essential workers before older adults can reduce infections and deaths, according to a modeling study published this week in the new open-access journal PLOS Global Public Health by Nicola Mulberry of Simon Fraser University, Canada, and colleagues. Credit: Mulberry et al., 2021, CC-BY 4.0 ([link] In areas […].

article thumbnail

SMC accepts Cabometyx/Opdivo combo for advanced kidney cancer patients

Pharma Times

In a Phase III study, the risk of death for advanced RCC patients was decreased by 34% with Cabometyx plus Opdivo treatment

108
108
article thumbnail

COVID Update: Mixing COVID-19 Vaccines Safe and Effective; Biden Presses Moderna

BioSpace

As the FDA prepares to discuss booster shots for Moderna and J&J vaccines, a new study came out suggesting that mixing and matching vaccines works well and is safe.

article thumbnail

The New Age of Decentralized Clinical Trials

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

article thumbnail

Artificial intelligence-based technology quickly identifies genetic causes of serious disease

Scienmag

An artificial intelligence (AI)-based technology rapidly diagnoses rare disorders in critically ill children with high accuracy, according to a report by scientists from University of Utah Health and Fabric Genomics, collaborators on a study led by Rady Children’s Hospital in San Diego. The benchmark finding, published in Genomic Medicine, foreshadows the next phase of medicine, […].

article thumbnail

MHRA backs Merck’s MET inhibitor Tepmetko

Pharma Times

Conditional marketing authorisation granted for patients with advanced NSCLC with METex14 skipping alterations

Marketing 109
article thumbnail

Solving mystery of rare cancers directly caused by HIV

Scienmag

PITTSBURGH, Oct. 13, 2021 – For nearly a decade, scientists have known that HIV integrates itself into genes in cells that have the potential to cause cancer. And when this happens in animals with other retroviruses, those animals often develop cancer. But, perplexingly and fortunately, that isn’t regularly happening in people living with HIV. Credit: […].

Gene 83
article thumbnail

Report: Multiple Suitors - Including BMS - Vied for Acceleron’s Attention

BioSpace

Merck and Acceleron struck an $11.5 billion merger agreement, but before that, rare-disease focused Acceleron Pharma was wooed by multiple suitors, including pharma giant Bristol Myers Squibb.

100
100
article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

Harvard researchers use dyes to store data

Scienmag

In the digital age, every byte of data needs to go somewhere — and preferably stay there a long time. That last part is a major problem when it comes to data-storage systems, which typically last less than 20 years. A group of Harvard chemists is trying to solve the issue with an innovation that […].

article thumbnail

Transition Bio Shifting into Second Gear with New Executive Team

BioSpace

Transition Bio named Gregory Miller as chief executive officer, Prof. Tuomas Knowles as chief technology officer and Martin Kulander as chief operating officer, among several others.

97
article thumbnail

Spark to use CombiGene therapy to target focal epilepsy

pharmaphorum

Spark Therapeutics has secured the exclusive rights to CombiGene’s CG01 therapy, which aims to treat drug resistant focal epilepsy, in a deal worth $8.5m in advance with further payments due on reaching clinical milestones. The news sent Swedish firm CombiGene’s shares soaring – almost doubling from SEK6.29 to SEK14.10 the following day, when the development was announced this week.

article thumbnail

Rectify Nets $100 Million to Help the Body Relearn its ABCs

BioSpace

Rectify emerged with a goal to develop disease-modifying precision therapies that will restore ABC transporter function in order to address the underlying cause of serious genetic disease.

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Large doses of intensive therapy better for children with cerebral palsy, multi-university study finds

Scienmag

Children with cerebral palsy can gain greater use of an impaired arm and hand with larger doses of Constraint-Induced Movement Therapy (CIMT) – without increasing stress for parents, according to a new study by researchers at Virginia Tech’s Fralin Biomedical Research Institute at VTC, UVA Children’s, The Ohio State University, and Nationwide Children’s Hospital.

article thumbnail

Venatorx’s Path to Novel Antibiotics – and Stopping another Pandemic

BioSpace

Less private investment and innovation in the development of new antibiotics are impeding efforts to combat drug-resistant infections.

article thumbnail

Researchers demonstrate a more effective personal protective equipment strategy for COVID-19

Scienmag

Credit: University Hospital Southampton Research by the University of Southampton and University Hospital Southampton has demonstrated that a newly-developed respirator hood is a safe form of personal protective equipment (PPE) for frontline healthcare workers and support staff. As well as being preferred by patients and staff to standard facemasks, they provide cost saving opportunities for the […].

article thumbnail

With No Clear Path Forward, Ardelyx Will Axe 102 More Jobs

BioSpace

?The FDA gave Ardelyx a CRL on the NDA but did not mention anything about clinical pharmacology or biopharmaceutics, safety, or any related non-clinical concerns.

96
article thumbnail

The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.

article thumbnail

All Roads In Clinical Research Can Lead To The CRA Destination But The Site Level May Be Fastest

Clinical Trial Gurus

While the clinical research associate position is a highly desired one, many pathways can lead one towards that destination. In my opinion, the best path to get one there is as a clinical research coordinator at a small research clinic.

article thumbnail

Telix’s MTRs are Advancing the Field of Precision Radio-Oncology

BioSpace

Modern radiation therapy is tightly targeted to dramatically reduce toxicity and side effects and often can be administered on an outpatient basis.

97
article thumbnail

Georgia state receives $5 million grant to establish a center of research excellence in science and technology

Scienmag

ATLANTA—A team of researchers at Georgia State University has been awarded a prestigious five-year, $5 million grant from the National Science Foundation’s Centers of Research Excellence in Science and Technology (CREST) program, which supports the research capabilities of minority-serving institutions through the establishment of centers that effectively integrate education and research.

article thumbnail

Broad Institute Names Chief Equity Officer in Commitment to Inclusive Medicine

BioSpace

Broad announced that it is bringing René Salazar on board as its first chief equity officer.

article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.